The ENEA Tech and Biomedical Foundation, as the lead investor with an investment of 2 million euros and in collaboration...
Harnessing Artificial Intelligence to Unlock the Therapeutic Potential of Plant Bioactives
A Revolutionary Approach to Biodiversity Conservation, Medicinal Discovery, and Sustainable Botanical Production “...
Fighting Glioblastoma: Could CAR-T Cell Therapy Be The Next Frontier?
Glioblastoma multiforme (GBM) is the most common and aggressive form of primary brain tumor, making up over 50% of all g...
Zoldasiran and Plozasiran – A New future for Familial Combined Hyperlipidemia
Take Home Message Two newly published manuscripts in the New England Journal of Medicine (N Engl J Med) support the effi...
Innovations in cortical organoids: accelerating glial development for neurological research.
Take-home message Glia-enriched cortical organoids with mature astrocytes offer a powerful platform to study astrocyte d...
AzurBio Pharma Launches to Fast-Track European Market Entry for Biopharma Companies with Breakthrough Treatments
PARIS, France, October 01, 2024 / Biotech Newswire / — AzurBio Pharma, specializing in bringing innovative pharmac...